Sevelamer Hydrochloride Tablet, Film Coated
Product Images NDC 72603-148

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Sevelamer Hydrochloride (NDC 72603-148). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

800mgbottle Label (800mgbottle Label)

800mgbottle Label (800mgbottle Label)
Label for Sevelamer Hydrochloride Tablets, 800 mg film-coated oral tablets. The package contains 180 tablets and is manufactured by Glenmark Pharmaceuticals Limited for NorthStar Rx LLC. The label includes storage instructions and a barcode. The NDC is 72603-148-01.*
FDA Label Image

Chemical-structure (Chemical Structure)

Chemical-structure (Chemical Structure)
Chemical structure diagram of sevelamer hydrochloride, showing repeating polymeric units with amine groups and hydroxy side chains associated with hydrochloride (HCl). The structure highlights the polymer backbone and functional groups relevant to the active ingredient.*
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
A line graph comparing the percentage of patients with at least a 2x reduction in serum phosphorus levels over a range of serum phosphorus reductions (mg/dL) for sevelamer hydrochloride and an active control. The x-axis shows reduction in serum phosphorus from negative to positive values; the y-axis shows percentage of patients, from 0 to 100%. The graph illustrates response distributions for both treatments relative to baseline, labeled with worsened increase to improved reduction.*
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
Line chart depicting phosphorus change from baseline over 52 study weeks comparing sevelamer hydrochloride and an active control. The x-axis represents study weeks (0 to 52), and the y-axis shows phosphorus change from baseline, ranging from -5 to 2. Two lines indicate treatment groups: sevelamer hydrochloride (solid circles) and active control (open squares), illustrating trends in phosphorus levels over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.